Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
NewsTIPS SA, as ‘2022's Leading Healthcare ICT Solutions Company’ for Latin America, has made itself an innovative, ingenuity-powered, and people-first business taking hospitals into the future.
M&AMore than three-fifths of US companies (61%) are planning deals in the next 12 months – the highest number ever recorded by EY's semiannual Global Capital Confidence Barometer.
LegalNegligence is a legal concept often used in car crash cases. It refers to a failure to exercise care, resulting in harm or injury to another person.
FinanceDid you know you can leave part (or all) of your death benefit from a life insurance policy as a donation to a charity or nonprofit organisation? Permanent life insurance policies, such as whole life insurance and universal life insurance, with their guarantee
NewseCommerce has become an essential part of doing business. No matter what kind of B2B company you have, it's critical to be able to reach out to customers online. You can do just that with a B2B eCommerce platform. Whether you're selling products or services,
InnovationThe Diagnosis and Treatment of PostTraumatic Stress Disorder
FinanceBrand consistency goes beyond visual elements. It influences customer trust, employee alignment, and overall business value. A consistent brand experience helps organizations strengthen relationships and maintain credibility during periods of change. Res
NewsAs more businesses begin to embrace the hybrid work model, the importance of adapting physical office spaces to ensure health, safety, and productivity continues to rise. Among other factors, efficient ventilation systems play a crucial role in this adaptation
FinanceBlue Owl Capital’s $2.4 Billion Sila Acquisition Makes the Case for Healthcare Net Lease Blue Owl Capital agreed on April 20 to pay $2.4 billion for Sila Realty Trust, a Tampa-based healthcare REIT with 137 net-leased properties across 65 U.S. markets. A
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
